What is the dosage of dexmethylphenidate (Azstarys)?

Dexmethylphenidate (Azstarys) dosage is designed based on patient age, clinical response, and tolerability to achieve the best balance of symptom control and safety. For children aged 6 to 12 years, the recommended starting dose is 39.2mg/7.8mg, taken orally once daily in the morning with food or on an empty stomach. After one week of use, based on symptom improvement and tolerance, the dose can be increased to 52.3 mg/10.4 mg once a day, or reduced to 26.1 mg/5.2 mg once a day as needed. The maximum daily dose is 52.3mg/10.4mg, ensuring optimal efficacy within a safe range.

For adolescents and adult patients 13 to 17 years old, the starting dose is also 39.2 mg/7.8 mg once daily. After one week of observation, the dose may be adjusted to 52.3 mg/10.4 mg once daily based on clinical response and tolerability. Azstarys uses a combination of immediate-release and sustained-release formulations, which can provide sustained effects throughout the day after one oral administration, maintaining stable blood concentration from getting up in the morning to nighttime activities. This design not only improves compliance, but also facilitates medication management at home and school, especially for students and working people who need attention support throughout the day.

During the course of taking the medication, doctors will regularly assess the patient's concentration, behavioral performance, and possible side effects, such as mild insomnia, decreased appetite, mild heart rate changes, or mild gastrointestinal discomfort. Through individualized dosage adjustment, Azstarys can achieve optimal efficacy within a safe range. Patients and parents should strictly follow the doctor's instructions and not increase or decrease the dosage at will, nor should they stop taking the medicine on their own to ensure continued improvement of symptoms.

In addition, in order to improve the treatment effect,The use of Azstarys is usually combined with behavioral intervention and educational support, including classroom management strategies, optimization of homework arrangements, and family behavioral training. Through this comprehensive management, the effects of medication can be further amplified, resulting in sustained improvements in academic performance, concentration, and impulse control. Azstarys' extended-release + immediate-release dosage form also reduces the frequency of medication and improves compliance, allowing children, adolescents and adults with attention deficit hyperactivity disorder (ADHD) to receive round-the-clock treatment support.

Reference materials:https://azstarys.com/